申请人:Hoechst Aktiengesellschaft
公开号:US04284786A1
公开(公告)日:1981-08-18
5-Methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and a process for its preparation is described. The compound has an antirheumatic, antiphlogistic, antipyretic and analgesic action, and can be used for the treatment of multiple sclerosis.
描述了5-甲基异噁唑-4-羧酸-(4-三氟甲基)-苯胺和其制备方法。该化合物具有抗风湿、抗炎、退烧和镇痛作用,并可用于治疗多发性硬化症。